leadf
logo-loader
viewTrutrace Technologies Inc.
(
CSE:TTTOTC:TTTSF
)

TruTrace Technologies announces the appointment of Allan O'Dette as chairman of its board and of Pradeep Sood as a director

O'Dette has over 30 years of experience in the public, private, not-for-profit and volunteer sectors driving organizational change and is currently the CEO of the Ontario Medical Association

Handshake
Sood has over 40 years of operations and management experience in Asia, Africa and North America, which has led to his deep knowledge and commitment to diversity and multiculturalism and is currently the president of the Board of Commonwealth Games Foundation of Canada

TruTrace Technologies Inc. (CSE:TTT) (OTCQB:TTTSF), the developer of a fully-integrated blockchain platform for the legal cannabis, food and pharmaceutical industries, has announced the appointment of Allan O'Dette as a director and chairman of its board and Pradeep Sood as a director.

The company noted that O'Dette has over 30 years of experience in the public, private, not-for-profit and volunteer sectors driving organizational change. He is currently the CEO of the Ontario Medical Association (OMA). Prior to this role, he was appointed the first chief investment officer for the Province of Ontario, and also led the revitalization of Canada’s largest business association The Ontario Chamber of Commerce for more than five years.

With more than 25 years of experience in the bio-pharmaceutical sector, O'Dette has been an advocate for Canadian businesses and served on a variety of private and not-for-profit boards and committees, including his role as vice-chair of the Markham Stouffville Hospital Board of Directors.

READ: TruTrace Technologies posts FY2020 revenue bump, slimmer loss

TruTrace pointed out that Sood has over 40 years of operations and management experience in Asia, Africa and North America, which has led to his deep knowledge and commitment to diversity and multiculturalism. He is currently the president of the Board of Commonwealth Games Foundation of Canada, a member of the board of Governors of George Brown College and a director on the board of Markham Stouffville Hospital Foundation.

“We are thrilled to welcome Allan and Pradeep to TruTrace’s Board of Directors,” said Robert Galarza, CEO of TruTrace in a statement. “Their combined expertise in guiding large organizations will bring valuable knowledge to TruTrace’s next phase of growth as a leader in ensuring supply chain transparency and product quality for the legal cannabis, food and pharmaceutical industries.”

The two new director join existing members Robert Galarza, Michael Kraft, Cesare Fazari and Cameron Chell on TruTrace's board

TruTrace Technologies is the developer of fully-integrated software, secured on a blockchain infrastructure, that gives clients’ the ability to store, manage, share and immediately access quality assurance and testing details, COAs, as well as motion and movement intelligence on inventory.

The platform was specifically designed to power the traceability of testing standards within the legal cannabis, nutraceutical, food and pharmaceutical space with a focus on the authentication of source materials or ingredients used in formulation.

Contact the author at jon.hopkins@proactiveinvestors.com

Quick facts: Trutrace Technologies Inc.

Follow
CSE:TTT

Price: 0.06 CAD

Market Cap: $9.16 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

TruTrace Technologies signs LOI to provide blockchain-secured ecosystem for...

TruTrace Technologies (CSE: TTT- OTCQB: TTTSF) CEO Robert Galarza joined Steve Darling from Proactive to bring news the company has announced that it has signed a letter of intent with Georgia-based PharmaCentra to support a clinical trial ecosystem built on standardized protocols and testing of...

on 03/02/2021

2 min read